The Oncology Institute, Inc.
TOI
$0.716
$0.09114.56%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.34% | 4.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.34% | 4.13% | |||
| Cost of Revenue | -0.02% | 3.45% | |||
| Gross Profit | 10.29% | 8.83% | |||
| SG&A Expenses | -4.40% | -2.04% | |||
| Depreciation & Amortization | 3.62% | 1.95% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.03% | 2.05% | |||
| Operating Income | 15.34% | 8.95% | |||
| Income Before Tax | -4.10% | 22.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.10% | 22.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.10% | 22.17% | |||
| EBIT | 15.34% | 8.95% | |||
| EBITDA | 17.28% | 9.93% | |||
| EPS Basic | -3.24% | 22.63% | |||
| Normalized Basic EPS | -2.87% | 23.20% | |||
| EPS Diluted | -5.88% | 22.73% | |||
| Normalized Diluted EPS | -2.87% | 23.20% | |||
| Average Basic Shares Outstanding | 1.04% | 0.69% | |||
| Average Diluted Shares Outstanding | 1.04% | 0.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
